Cargando…

Regulatory pathways and drugs associated with ferroptosis in tumors

Ferroptosis is a type of cell death that depends on iron and reactive oxygen species (ROS). The accumulation of iron and lipid peroxidation primarily initiates oxidative membrane damage during ferroptosis. The core molecular mechanism of ferroptosis includes the regulation of oxidation and the balan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dan, Tang, Le, Zhang, Yijie, Ge, Guili, Jiang, Xianjie, Mo, Yongzhen, Wu, Pan, Deng, Xiangying, Li, Lvyuan, Zuo, Sicheng, Yan, Qijia, Zhang, Shanshan, Wang, Fuyan, Shi, Lei, Li, Xiayu, Xiang, Bo, Zhou, Ming, Liao, Qianjin, Guo, Can, Zeng, Zhaoyang, Xiong, Wei, Gong, Zhaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187756/
https://www.ncbi.nlm.nih.gov/pubmed/35688814
http://dx.doi.org/10.1038/s41419-022-04927-1
_version_ 1784725235940982784
author Wang, Dan
Tang, Le
Zhang, Yijie
Ge, Guili
Jiang, Xianjie
Mo, Yongzhen
Wu, Pan
Deng, Xiangying
Li, Lvyuan
Zuo, Sicheng
Yan, Qijia
Zhang, Shanshan
Wang, Fuyan
Shi, Lei
Li, Xiayu
Xiang, Bo
Zhou, Ming
Liao, Qianjin
Guo, Can
Zeng, Zhaoyang
Xiong, Wei
Gong, Zhaojian
author_facet Wang, Dan
Tang, Le
Zhang, Yijie
Ge, Guili
Jiang, Xianjie
Mo, Yongzhen
Wu, Pan
Deng, Xiangying
Li, Lvyuan
Zuo, Sicheng
Yan, Qijia
Zhang, Shanshan
Wang, Fuyan
Shi, Lei
Li, Xiayu
Xiang, Bo
Zhou, Ming
Liao, Qianjin
Guo, Can
Zeng, Zhaoyang
Xiong, Wei
Gong, Zhaojian
author_sort Wang, Dan
collection PubMed
description Ferroptosis is a type of cell death that depends on iron and reactive oxygen species (ROS). The accumulation of iron and lipid peroxidation primarily initiates oxidative membrane damage during ferroptosis. The core molecular mechanism of ferroptosis includes the regulation of oxidation and the balance between damage and antioxidant defense. Tumor cells usually contain a large amount of H(2)O(2), and ferrous/iron ions will react with excessive H(2)O(2) in cells to produce hydroxyl radicals and induce ferroptosis in tumor cells. Here, we reviewed the latest studies on the regulation of ferroptosis in tumor cells and introduced the tumor-related signaling pathways of ferroptosis. We paid particular attention to the role of noncoding RNA, nanomaterials, the role of drugs, and targeted treatment using ferroptosis drugs for mediating the ferroptosis process in tumor cells. Finally, we discussed the currently unresolved problems and future research directions for ferroptosis in tumor cells and the prospects of this emerging field. Therefore, we have attempted to provide a reference for further understanding of the pathogenesis of ferroptosis and proposed new targets for cancer treatment.
format Online
Article
Text
id pubmed-9187756
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91877562022-06-12 Regulatory pathways and drugs associated with ferroptosis in tumors Wang, Dan Tang, Le Zhang, Yijie Ge, Guili Jiang, Xianjie Mo, Yongzhen Wu, Pan Deng, Xiangying Li, Lvyuan Zuo, Sicheng Yan, Qijia Zhang, Shanshan Wang, Fuyan Shi, Lei Li, Xiayu Xiang, Bo Zhou, Ming Liao, Qianjin Guo, Can Zeng, Zhaoyang Xiong, Wei Gong, Zhaojian Cell Death Dis Review Article Ferroptosis is a type of cell death that depends on iron and reactive oxygen species (ROS). The accumulation of iron and lipid peroxidation primarily initiates oxidative membrane damage during ferroptosis. The core molecular mechanism of ferroptosis includes the regulation of oxidation and the balance between damage and antioxidant defense. Tumor cells usually contain a large amount of H(2)O(2), and ferrous/iron ions will react with excessive H(2)O(2) in cells to produce hydroxyl radicals and induce ferroptosis in tumor cells. Here, we reviewed the latest studies on the regulation of ferroptosis in tumor cells and introduced the tumor-related signaling pathways of ferroptosis. We paid particular attention to the role of noncoding RNA, nanomaterials, the role of drugs, and targeted treatment using ferroptosis drugs for mediating the ferroptosis process in tumor cells. Finally, we discussed the currently unresolved problems and future research directions for ferroptosis in tumor cells and the prospects of this emerging field. Therefore, we have attempted to provide a reference for further understanding of the pathogenesis of ferroptosis and proposed new targets for cancer treatment. Nature Publishing Group UK 2022-06-10 /pmc/articles/PMC9187756/ /pubmed/35688814 http://dx.doi.org/10.1038/s41419-022-04927-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Wang, Dan
Tang, Le
Zhang, Yijie
Ge, Guili
Jiang, Xianjie
Mo, Yongzhen
Wu, Pan
Deng, Xiangying
Li, Lvyuan
Zuo, Sicheng
Yan, Qijia
Zhang, Shanshan
Wang, Fuyan
Shi, Lei
Li, Xiayu
Xiang, Bo
Zhou, Ming
Liao, Qianjin
Guo, Can
Zeng, Zhaoyang
Xiong, Wei
Gong, Zhaojian
Regulatory pathways and drugs associated with ferroptosis in tumors
title Regulatory pathways and drugs associated with ferroptosis in tumors
title_full Regulatory pathways and drugs associated with ferroptosis in tumors
title_fullStr Regulatory pathways and drugs associated with ferroptosis in tumors
title_full_unstemmed Regulatory pathways and drugs associated with ferroptosis in tumors
title_short Regulatory pathways and drugs associated with ferroptosis in tumors
title_sort regulatory pathways and drugs associated with ferroptosis in tumors
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187756/
https://www.ncbi.nlm.nih.gov/pubmed/35688814
http://dx.doi.org/10.1038/s41419-022-04927-1
work_keys_str_mv AT wangdan regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT tangle regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT zhangyijie regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT geguili regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT jiangxianjie regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT moyongzhen regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT wupan regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT dengxiangying regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT lilvyuan regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT zuosicheng regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT yanqijia regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT zhangshanshan regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT wangfuyan regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT shilei regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT lixiayu regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT xiangbo regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT zhouming regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT liaoqianjin regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT guocan regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT zengzhaoyang regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT xiongwei regulatorypathwaysanddrugsassociatedwithferroptosisintumors
AT gongzhaojian regulatorypathwaysanddrugsassociatedwithferroptosisintumors